Graduate School of Medicine/Graduate School of Public Health
Staff Information
Yutaka Takahashi
MD, PhD
Graduate School of Medicine, Affiliation Campus: Narita
Specialized Field
Clinical oncology、Cancer metastasis、Cancer biology
Message to Students
I proposed that prolonged survival by tumor dormancy rather than complete remission of tumors in metastatic cancer patients. My goal is that longer survival with less toxic and better QOL by molecular targeted drug and tailored dose chemotherapy in metastatic cancer patients.
Research Theme
Molecules and genes associated with cancer metastasis
Angiogenesis
Individualized chemotherapy
References
- Takahashi Y, et al: Platelet-derived endothelial cell growth factor in humancolon cancer angiogenesis: Role of infiltrating cells. J Natl Cancer Inst 88: 1146-1151, 1996.
- Takahashi Y, et al: Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 55: 3964-3968, 1995.
- Takahashi Y, et al: Significance of vessel count, vascular endothelial growth factor, and its receptor (KDR) in intestinal-type gastric cancer. Clin Cancer Res 2: 1679-1684,1996.
- Takahashi Y, et al: Significance of platelet-derived endothelial cell growth factor in the angiogenesis of human gastric cancer. Clin Cancer Res 4: 429-434, 1998.
- Takahashi Y, et al: Survival without tumor shrinkage: Re-evaluation of survival gain by cytostatic effect of chemotherapy. J Natl Cancer Inst 87: 1262-1263, 1995.